Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Business Wire•29/07/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.